METAFLAM® 2.5 MG Chewable Tablet

Manufacturer/Marketer: SAVA Vet / SAVA Healthcare Limited
Product Type: Veterinary NSAID / Pain-Relief Medicine
Therapeutic Class: Non-Steroidal Anti-Inflammatory Drug (NSAID) – Analgesic, Anti-inflammatory & Antipyretic
Target Species: Dogs
Dosage Form: Chewable tablet
Strength: 2.5 mg
Presentation: Blister of 10 tablets
Route: Oral
Prescription Status: For use under veterinary supervision. 

Composition

Each METAFLAM 2.5 MG Tablet contains:

• Meloxicam BP – 2.5 mg
• Approved flavours
• Colours: Iron Oxide Red and Iron Oxide Yellow. 

Clinical Description

METAFLAM contains Meloxicam, an NSAID of the oxicam group. It inhibits prostaglandin synthesis and thereby produces anti-inflammatory, analgesic, anti-exudative and antipyretic effects. SAVA's product information states that meloxicam is 97% bound to canine plasma proteins. 

Indications / Recommended Uses

METAFLAM is indicated for the relief of pain and inflammation associated with acute and chronic musculoskeletal disorders in dogs, including veterinarian-diagnosed painful inflammatory conditions. 

Dosage & Administration

Initial dose on Day 1: Meloxicam 0.2 mg/kg body weight

Maintenance dose from Day 2: Meloxicam 0.1 mg/kg body weight once daily. 

For METAFLAM 2.5 mg tablets, SAVA's maintenance-dose chart specifies:

The tablets can be halved for accurate dosing and may be administered with or without food. 

Duration of Treatment

Clinical response is usually seen within 3–4 days. SAVA's insert states that treatment should be discontinued and the case reassessed if no clinical improvement is apparent after 10 days. 

Key Benefits

• Effective pain relief
• Reduces inflammation and swelling
• Helps manage acute and chronic musculoskeletal pain
• Provides antipyretic activity
• Convenient once-daily maintenance dosing
• Scored/halvable chewable tablet for weight-based dosing. 

Contraindications & Precautions

Meloxicam should be used only under veterinary supervision. Extra caution is appropriate in dogs with gastrointestinal, kidney, liver, cardiac or bleeding disorders, or in dehydrated/hypovolaemic animals.

Do not combine meloxicam with another NSAID or corticosteroid unless specifically directed by a veterinarian, because this can increase the risk of gastrointestinal ulceration and other adverse effects.

Possible Adverse Effects

NSAID-related adverse reactions can include vomiting, diarrhoea, loss of appetite, lethargy, gastrointestinal irritation/ulceration, and renal or hepatic abnormalities. Stop treatment and contact the veterinarian if significant adverse signs develop.

Withdrawal Period

Not applicable — METAFLAM tablets are labelled for dogs, not food-producing animals. 

Storage

Store below 25°C, protected from inappropriate heat and moisture. Keep out of reach of children and animals. 

Important Warning

FOR VETERINARY USE ONLY – FOR DOGS.

Do not give additional painkillers, NSAIDs or corticosteroids alongside METAFLAM without veterinary advice. Dose carefully according to the dog's actual body weight.

Rayavets Short Description

METAFLAM 2.5 MG Chewable Tablet by SAVA Vet contains Meloxicam 2.5 mg, an NSAID with analgesic, anti-inflammatory and antipyretic activity for dogs. It is indicated for relief of pain and inflammation associated with acute and chronic musculoskeletal disorders. Recommended meloxicam dosage is 0.2 mg/kg on the first day followed by 0.1 mg/kg once daily for maintenance. The 2.5 mg tablet corresponds to the maintenance dose for approximately a 25 kg dog and can be halved for weight-based dosing. Pack: 10 chewable tablets.